CATHY KLEMA
CIK 1181157 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$293.6K
Companies
7
Total Filings
36
Lifetime Open-Market Net
-$2.48M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OPRX | Director | 56,137 | $5.23 | $293.6K | $0 | 5 | 2026-06-10 |
| Allergan plc (AGN) Delisted | Director | 25,081 | — | — | $0 | 3 | 2019-05-02 |
| Allergan plc (AGNpA) Delisted | Director | 23,639 | — | — | $0 | 4 | 2017-05-05 |
| Allergan plc (ACTpA) Delisted | Director | 21,027 | — | — | $0 | 1 | 2015-06-08 |
| ACT | Director | 0 | $42.41 | $0 | $0 | 1 | 2013-10-02 |
| Actavis, Inc. (WPI) Delisted | Director | 44,432 | — | — | -$1.70M | 7 | 2012-08-01 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 16,199 | — | — | -$774.3K | 12 | 2011-01-04 |
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-01-04 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | +2,355 | $0 | EDGAR |
| 2010-08-02 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-21 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-11 | Actavis, Inc. (WPI) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2010-01-05 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | +2,799 | $0 | EDGAR |
| 2009-05-22 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-05-11 | Actavis, Inc. (WPI) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2009-01-05 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | +2,242 | $0 | EDGAR |
| 2008-05-29 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Mixed | — | -$240.0K | EDGAR |
| 2008-05-22 | PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.